Rick Doblin — The Psychedelic Domino That Tips All Others | Brought to you by Helix Sleep and LinkedIn JobsRick Doblin, PhD, (@rickdoblin) is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in public policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. Rick was also one of the early students under the legendary Dr. Stanislav Grof.Please listen to this entire episode, as there is a $10M surprise at the end.If you are interested in learning more about MAPS’s critical work and Phase 3 studies to make MDMA-assisted psychotherapy an approved treatment for PTSD, please visit maps.org/capstoneThis podcast episode is brought to you by Helix Sleep! Helix was selected as the #1 best overall mattress pick of 2020 by GQ magazine, Wired, Apartment Therapy, and many others. With Helix, there’s a specific mattress for each and everybody’s unique taste. Just take their quiz—only two minutes to complete—that matches your body type and sleep preferences to the perfect mattress for you. They have a 10-year warranty, and you get to try it out for a hundred nights, risk free. They’ll even pick it up from you if you don’t love it. And now, to my dear listeners, Helix is offering up to 200 dollars off all mattress orders plus two free pillows at HelixSleep.com/TIM.This episode is also brought to you by LinkedIn Jobs. Whether you are looking to hire now for a critical role or thinking about needs that you may have in the future, LinkedIn Jobs can help. LinkedIn is an active community with more than 675 million members worldwide. LinkedIn screens candidates for the hard and soft skills you’re looking for and puts your job in front of candidates looking for job opportunities that match what you have to offer.With LinkedIn, you can hire the right person quickly when you need them. And if you need to hire for healthcare or essential services, you can post your jobs for free. When it’s time to find and hire that right person, LinkedIn is here to help. Just visit LinkedIn.com/Tim to get started! Terms and conditions apply.***If you enjoy the podcast, would you please consider leaving a short review on Apple Podcasts/iTunes? It takes less than 60 seconds, and it really makes a difference in helping to convince hard-to-get guests.For show notes and past guests, please visit tim.blog/podcast.Sign up for Tim’s email newsletter (“5-Bullet Friday”) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Interested in sponsoring the podcast? Please fill out the form at tim.blog/sponsor.Discover Tim’s books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissFacebook: facebook.com/timferriss YouTube: youtube.com/timferriss
Imagine it: Your doctor tells you, “Take a magic mushroom and call me in the morning.”It’s...probably not all that realistic. But the promise of psychedelic-assisted psychotherapy? Definitely realistic. And definitely an intriguing business prospect.That’s why this week on Business Casual, we’re talking to the preeminent expert in the controlled use of psychedelic drugs: Dr. Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (aka MAPS).Rick has spent nearly four decades at MAPS championing the uses of psychedelics and marijuana in clinical settings. The treatment possibilities, as he sees them, range from post-traumatic stress disorder to depression to addiction.Sounds promising—but there’s always a but. The larger pharmaceuticals, biotech, and insurance industries aren’t quite ready to wholly buy into psychedelic-assisted psychotherapy. Or psychotherapy of any kind, for that matter.Along with earning a spot in the regulatory good graces of U.S. officials, educating business decision makers presents a challenge for Rick and his peers in the psychedelics space. But if the trend of microdosing (ahem, Silicon Valley) is any indication, interest is growing from both venture capital and consumer POVs.Money, though, is harder to come by—in the episode, Rick shares the experience of fundraising as a nonprofit.The tl;dr? It’s really, really hard.Listen now to expand your mind.Rick generously offered to answer other business-related questions. Get in touch with him at firstname.lastname@example.org.
When psychedelic drugs finally become legal in the United States and elsewhere around the world, the lion's share of the credit will go to Rick Doblin. Since founding the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986, Doblin has argued forcefully for the benefits of frequently demonized substances such as MDMA, LSD, psilocybin, and ibogaine in helping people cope with post-traumatic stress disorder (PTSD), depression, anxiety, and other debilitating problems.
MAPS is currently sponsoring phase three clinical trials of MDMA-assisted psychotherapy as a treatment for PTSD. Within the next few years, if all goes well, the Food and Drug Administration (FDA) is expected to approve MDMA—which the federal government banned in 1985 as a dangerous party drug then known as ecstasy—for use by prescription as a psychotherapeutic catalyst. Further down the line, psychedelic drugs such as LSD and psilocybin, which the FDA has recognized as a "breakthrough therapy" for depression, could undergo a similar legal transformation.
Although MAPS is doing everything by the book in seeking approval of MDMA as a prescription drug, Doblin's vision goes beyond such doctor-approved uses. He aspires to a world in which people can use psychedelics responsibly without permission from physicians or priests. "Psychedelics are tools," Doblin says. "They're not good or bad in and of themselves. It's how they are used. It's the relationship you have with them…People should have the fundamental human right to change their consciousness."
Because of his busy schedule, Doblin spoke with Reason Editor at Large Nick Gillespie in late February in the back of an Uber headed to John F. Kennedy Airport. The unconventional setting seemed the perfect place to catch up with a guy who is doing so much to radically change our way of thinking about how we deal with the world.
Audio production by Regan Taylor and Ian Keyser.
This episode we feature the founder of MAPS (Multidisciplinary Association for Psychedelic Studies), Rick Doblin, Ph. D. Rick will go down in history as one of the greatest contributors to the legalization of psychedelic medicines which, as we discuss with him, will have an evolutionary shift for mental health and quite possibly a relative harmonization-effect upon the human race.
Rick takes us through some of the key milestones of the 30+ year journey of MAPS as well as share the next big steps ahead as they work to have MDMA acknowledged to become a prescription medicine with it’s combinatory work with psychotherapy to treat PTSD.
Please share this message and donate what you can.